AstraZeneca

AstraZeneca’s potential takeover by Pfizer may lead to thousands of job cuts

The potential takeover of British pharmaceuticals firm AstraZeneca by American drugs giant Pfizer has raised concerns about the future of British firm's employees.

Companies: 
General: 
People: 

AstraZeneca’s acquisition will make lot of sense for Pfizer: says analyst

The recently published report about Pfizer's supposed interest in British drugmaker AstraZeneca has prompted many experts to predict that such a deal would make a lot of sense for the U. S. pharmaceuticals giant.

Companies: 
General: 

Pfizer interested in AstraZeneca: report

American pharmaceuticals giant Pfizer Inc is reportedly mulling a plan to place a bid for struggling British drugs-maker AstraZeneca.

General: 
Companies: 

EU Approves AstraZenec’s Brilique

On Friday, the Health Regulators at the European Medicines Agency granted AstraZeneca Plc, the second largest drug manufacturer in the UK, its premarket approval on Brilinta, the new blood thinner and heart drug. The Committee for Medicinal Products for Human Use of the European Medicines Agency stated that Brilique, also known as Brilinta, would reduce the risks of heart attacks when used in combination with aspirin.

General: 
Companies: 

AstraZeneca's Anticlotting drug faces three-month FDA delay

U.S. have delayed the project experimental blood thinner, ticagrelor by three months by the U.K.'s second-biggest drug maker AstraZeneca PLC's (AZN.LN).

The firm has asked to grant few more days in order to release the version to Dec. 16.

Ticagrelor, which has been released brand name Brilinta that falls under the hit drug of AstraZeneca and is at the moment under the review by firms of the European Union, Canada, and Brazil.

Region: 
General: 
Companies: 

Pages

Subscribe to RSS - AstraZeneca